Skip to Main Content

Paper Details

Second-Line Pharmaceutical Treatments for Patients with Type 2 Diabetes.
JAMA Netw Open
2
2023
Author NameAffiliation
Lisa DahmCenter for Data-driven Insights and Innovation, University of California Health
Atul J ButteBakar Computational Health Sciences Institute, University of California san francisco
Atul J ButteCenter for Data-driven Insights and Innovation, University of California Health
  • 1 - 3

Datasets